Exome Sequencing Study Narrows in on New Cushing's Syndrome Gene Culprit

Feb 28, 2014

|

NEW YORK (GenomeWeb News) – In a study published online this week in the New England Journal of Medicine, an international team described new mutations involved in a severe form of Cushing's syndrome caused by adrenal adenoma tumors or overgrowths rather than excess pituitary gland activity.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Genome of an Oak

A new study catalogues the genome and evolutionary history of the oak family, UPI reports.

'Mostly Chihuahua, or Mostly Rat Terrier'

Dog DNA testing is a growing market, but there's still a lot of uncertainty about the accuracy of the results, the Boston Globe says.

Amelia, Is That You?

A University of South Florida researcher is testing bone fragments to determine if they belong to Amelia Earhart.

Cell Papers Explore Koala Genome Retrovirus Responses, Liver Cancer Proteomics, More

In Cell this week: antisense Piwi-interacting RNA responses to endogenous retroviruses, proteomic patterns in hepatocellular carcinoma, and more.

Featured White Papers

The 'Dark Matter' of Cancer Genomics: Revealing Undetected Structural Variants

Analytical Validation of the Oncomine Pan-Cancer Cell-Free Assay

A High-Performance Solution Combining CleanPlex OncoZoom Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations

BlueBee Data Security & Compliance

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Oct

31

Featured Webinar

The Power of Automation for NGS Capture Enrichment: Uniformity and Speed

This webinar will provide an overview of how the Center for Applied Genomics at Children's Hospital of Philadelphia has optimized its next-generation sequencing (NGS) workflow using a combination of PerkinElmer's Sciclone automation technology and target capture chemistry from Twist Bioscience.

Menu